A check up on the health care sector, with Chris Viehbacher, Sanofi-Aventis CEO, who shares his outlook for 2012.
We are seeing a slow recovery in the U.S. and while there are challenges there are opportunities to take advantage of the slow recovery, says William Weldon, Johnson & Johnson chairman/CEO.
Idenix is up on Inhibitex deal. The traders take a look at Bristol Meyers acquisition of Inhibitex for $2.6 billion.
The "Patient Protection and Affordable Care Act" has been a lightning rod since its inception. Both sides of the aisle have used a different set of numbers to support stances both for and against the law.
What follows is a list of jobs that may be prevalent in the 21st century. What they all have in common is they offer prospects to those entering the workforce for the rest of the century.
It pays to be young. but if you want to convey reliability, wisdom or gravitas, people over age 50 have the edge. See the new careers for workers over 50.
Pharmaceutical giants’ profits could take a "double-dip" hit next year from patent expirations on blockbuster drugs and President Barack Obama’s healthcare reforms, according to a report from CreditSights, a credit market research firm.
Are there really jobs with flexible hours, fantastic locations and copious vacation time that also net a decent paycheck? What follows is a list of jobs with the potential for high pay and low stress.
BGI, based in China, is the world’s largest genomics research institute, with 167 DNA sequencers producing the equivalent of 2,000 human genomes a day, the New York Times reports.
Physicians are embracing Web-based software solutions that are bringing healthcare services into the home.
The job search portal CareerCast.com created a list of 12 jobs that look better on paper than they might be in reality. Check to see if your job is on the list!
The pharmaceutical company reported third-quarter profit and revenue above analyst forecasts on Friday, and said it expected mid-sigle digit revenue growth for the full year.
Is legislated healthcare reform here to stay? As we watch the presidential race heat up – and look to a Supreme Court ruling this summer — no one knows for sure. Regardless, we as a nation need to realize that traditional thinking around healthcare is forever changed.
A question that is becoming more pertinent in these straightened economic times is whether it is possible to measure charitable initiatives the way businesses measure their profits.
The US economy is now taking a bite out of dentist office sales, with Lawrence Marsh, Barclays Capital sr. research analyst.
Coming in to work when you’re sick costs businesses billions a year in lost productivity, but many workplaces can make employees sick. Here are 10 ways that your work may be killing you and your employer.
Investors should purchase pharmaceuticals shares in firms such as Roche, AstraZeneca, Novartis, and GlaxoSmithKline, James Bevan, CIO at CCLA Investment Management, told CNBC Friday.
What are some of the most notable multimillion-dollar sports injuries? Check out the list.
Counterfeit prescription pharmaceuticals are widely recognized as a growing public health risk and a serious concern to public health officials, private companies, and consumers. Learn more.
A spokesman for the medical-technology industry warned that a new medical-device tax that goes into effect in 2013 under the Obama health-care law could force some companies to cut jobs.